Citation
Kämpjärvi, Kati, et al. "Mutations in Exon 1 Highlight the Role of MED12 in Uterine Leiomyomas." Human Mutation, vol. 35, no. 9, 2014, pp. 1136-41.
Kämpjärvi K, Park MJ, Mehine M, et al. Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat. 2014;35(9):1136-41.
Kämpjärvi, K., Park, M. J., Mehine, M., Kim, N. H., Clark, A. D., Bützow, R., Böhling, T., Böhm, J., Mecklin, J. P., Järvinen, H., Tomlinson, I. P., van der Spuy, Z. M., Sjöberg, J., Boyer, T. G., & Vahteristo, P. (2014). Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Human Mutation, 35(9), 1136-41. https://doi.org/10.1002/humu.22612
Kämpjärvi K, et al. Mutations in Exon 1 Highlight the Role of MED12 in Uterine Leiomyomas. Hum Mutat. 2014;35(9):1136-41. PubMed PMID: 24980722.
TY - JOUR
T1 - Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas.
AU - Kämpjärvi,Kati,
AU - Park,Min Ju,
AU - Mehine,Miika,
AU - Kim,Nam Hee,
AU - Clark,Alison D,
AU - Bützow,Ralf,
AU - Böhling,Tom,
AU - Böhm,Jan,
AU - Mecklin,Jukka-Pekka,
AU - Järvinen,Heikki,
AU - Tomlinson,Ian P M,
AU - van der Spuy,Zephne M,
AU - Sjöberg,Jari,
AU - Boyer,Thomas G,
AU - Vahteristo,Pia,
Y1 - 2014/07/21/
PY - 2014/04/15/received
PY - 2014/06/17/accepted
PY - 2014/7/2/entrez
PY - 2014/7/2/pubmed
PY - 2015/5/12/medline
KW - MED12
KW - benign tumor
KW - cancer
KW - somatic mutation
KW - uterine leiomyoma
SP - 1136
EP - 41
JF - Human mutation
JO - Hum Mutat
VL - 35
IS - 9
N2 - Mediator regulates transcription by connecting gene-specific transcription factors to the RNA polymerase II initiation complex. We recently discovered by exome sequencing that specific exon 2 mutations in mediator complex subunit 12 (MED12) are extremely common in uterine leiomyomas. Subsequent screening studies have focused on this mutational hot spot, and mutations have been detected in uterine leiomyosarcomas, extrauterine leiomyomas and leiomyosarcomas, endometrial polyps, and colorectal cancers. All mutations have been missense changes or in-frame insertions/deletions. Here, we have analyzed 611 samples representing all above-mentioned tumor types for possible exon 1 mutations. Five mutations were observed, all of which were in-frame insertion/deletions in uterine leiomyomas. Transcriptome-wide expression data revealed that MED12 exon 1 and exon 2 mutations lead to the same unique global gene expression pattern with RAD51B being the most upregulated gene. Immunoprecipitation and kinase activity assays showed that both exon 1 and exon 2 mutations disrupt the interaction between MED12 and Cyclin C and CDK8/19 and abolish the mediator-associated CDK kinase activity. These results further emphasize the role of MED12 in uterine leiomyomas, show that exon 1 and exon 2 exert their tumorigenic effect in similar manner, and stress that exon 1 should be included in subsequent MED12 screenings.
SN - 1098-1004
UR - https://www.unboundmedicine.com/medline/citation/24980722/Mutations_in_Exon_1_highlight_the_role_of_MED12_in_uterine_leiomyomas_
L2 - https://doi.org/10.1002/humu.22612
DB - PRIME
DP - Unbound Medicine
ER -